A Phase 3 randomized placebo contolled parellel-group multicenter double blined study to evaluate the efficacy and safetyof Telotristat Etiprate
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Lexicon Pharmaceuticals
Start Date
September 1, 2014
End Date
October 27, 2015
Administered By
Duke Cancer Institute
Awarded By
Lexicon Pharmaceuticals
Start Date
September 1, 2014
End Date
October 27, 2015